Literature DB >> 18606864

Deletion of Go2alpha abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system.

Irene Brunk1, Christian Blex, Carles Sanchis-Segura, Jan Sternberg, Stephanie Perreau-Lenz, Ainhoa Bilbao, Heide Hörtnagl, Jens Baron, Judyta Juranek, Gregor Laube, Lutz Birnbaumer, Rainer Spanagel, Gudrun Ahnert-Hilger.   

Abstract

The alpha-subunits of the trimeric Go class of GTPases, comprising the splice variants Go1alpha and Go2alpha, are abundantly expressed in brain and reside on both plasma membrane and synaptic vesicles. Go2alpha is involved in the vesicular storage of monoamines but its physiological relevance is still obscure. We now show that genetic depletion of Go2alpha reduces motor activity induced by dopamine-enhancing drugs like cocaine, as repeated injections of cocaine fail to provoke behavioral sensitization in Go2alpha(-/-) mice. In Go2alpha(-/-) mice, D1 receptor signaling in the striatum is attenuated due to a reduced expression of Golf alpha and Gs alpha. Following cocaine treatment, Go2alpha(-/-) mice have lower D1 and higher D2 receptor amounts compared to wild-type mice. The lack of behavioral sensitization correlates with reduced dopamine levels in the striatum and decreased expression of tyrosine hydroxylase. One reason for the neurochemical changes may be a reduced uptake of monoamines by synaptic vesicles from Go2alpha(-/-) mice as a consequence of a lowered set point for filling. We conclude that Go2alpha optimizes vesicular filling which is instrumental for normal dopamine functioning and for the development of drug-induced behavioral sensitization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606864      PMCID: PMC2537433          DOI: 10.1096/fj.08-111245

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  35 in total

1.  Most central nervous system D2 dopamine receptors are coupled to their effectors by Go.

Authors:  M Jiang; K Spicher; G Boulay; Y Wang; L Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

2.  G(olf)alpha mediates dopamine D1 receptor signaling.

Authors:  X Zhuang; L Belluscio; R Hen
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 3.  The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins.

Authors:  G R Uhl; S Li; N Takahashi; K Itokawa; Z Lin; M Hazama; I Sora
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

Review 4.  Regulation of vesicular neurotransmitter transporters.

Authors:  G Ahnert-Hilger; M Höltje; I Pahner; S Winter; I Brunk
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-09-27       Impact factor: 5.545

5.  The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2).

Authors:  M Höltje; B von Jagow; I Pahner; M Lautenschlager; H Hörtnagl; B Nürnberg; R Jahn; G Ahnert-Hilger
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

6.  Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.

Authors:  I Sora; F S Hall; A M Andrews; M Itokawa; X F Li; H B Wei; C Wichems; K P Lesch; D L Murphy; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 7.  D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action.

Authors:  Michele Hummel; Ellen M Unterwald
Journal:  J Cell Physiol       Date:  2002-04       Impact factor: 6.384

8.  The light response of ON bipolar neurons requires G[alpha]o.

Authors:  A Dhingra; A Lyubarsky; M Jiang; E N Pugh; L Birnbaumer; P Sterling; N Vardi
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

9.  Light response of retinal ON bipolar cells requires a specific splice variant of Galpha(o).

Authors:  Anuradha Dhingra; Meisheng Jiang; Tian-Li Wang; Arkady Lyubarsky; Andrey Savchenko; Tehilla Bar-Yehuda; Peter Sterling; Lutz Birnbaumer; Noga Vardi
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

10.  Cocaine sensitization and reward are under the influence of circadian genes and rhythm.

Authors:  Carolina Abarca; Urs Albrecht; Rainer Spanagel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

View more
  7 in total

Review 1.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

Review 3.  Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders.

Authors:  Stephen J Glatt; Ori S Cohen; Stephen V Faraone; Ming T Tsuang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-03-22       Impact factor: 3.568

4.  A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  J Neurosci Methods       Date:  2012-06-12       Impact factor: 2.390

5.  A verification of previously identified QTLs for cocaine-induced activation using a panel of B6.A chromosome substitution strains (CSS) and A/J x C57Bl/6J F2 mice.

Authors:  Alan E Boyle; Kathryn J Gill
Journal:  Psychopharmacology (Berl)       Date:  2009-09-23       Impact factor: 4.530

6.  The α-subunit of the trimeric GTPase Go2 regulates axonal growth.

Authors:  Jens Baron; Christian Blex; Astrid Rohrbeck; Sivarama Krishna Rachakonda; Lutz Birnbaumer; Gudrun Ahnert-Hilger; Irene Brunk
Journal:  J Neurochem       Date:  2013-02-03       Impact factor: 5.372

7.  Adaptive gene regulation in the Striatum of RGS9-deficient mice.

Authors:  Kathy Busse; Rainer Strotmann; Karl Strecker; Florian Wegner; Vasudharani Devanathan; Antje Gohla; Torsten Schöneberg; Johannes Schwarz
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.